Mark Beer Renovia

Mark Beer grew up in Ohio where he studied at the Miami University graduating with the Bachelor Science. The individual qualifies with over 25 years of experience in development and commercialization in devices, diagnostic, pharmaceutical, and biotechnology. Together with Yolanda Lurie and Roman Iglesias, Beer established the Renovia Inc in August 2016. Soon after the establishment, the leaders completed a Series A funding round. Renovia is a demonstration of a line of various successful establishments of Beer. The primary focus and developments of beer touch on technological convergences and medicine.


Every individual trusts Mark Beer as the optimal leader of Renovia considering his level of experience and accomplishment and the leadership positions he held before. Beer and his team completed a $42-million Series B funding that showed significant improvement not just for Renovia but for Beer. Beer garnered leadership skills and attention after becoming the founder and the CEO of ViaCell. The biotechnology company manages the preservation, collection, and development of the umbilical cord stem cells. The biotech company went public in 2005 after garnering more than 300 workers. Later, after two years, Perkin Elmer took the possession of ViaCell. Before he became the CEO of ViaCell, Mark Beer served in various leadership positions including the executive vice president of global marketing. Every position Beer held would open up much experience not just in medicine but knowing what people need, especially when working at Renovia.


The finishing of the Series B funding round will help in reinforcing the growth of medical technology devices meant to treat, diagnose, and prevent pelvic floor disorders, such as the urinary incontinence. As the CEO, Mark Beer expressed appreciations to every individual who took part in development to allow the Boston-base MedTech Company to enhance on its existing products and come up with new ones. All the uniqueness in treating and diagnosing the pelvic floor disorders of Renovia get attributed to Beer through his experience and high level of education and expertise.


The primary focus of Renovia is to enhance the technology that will assist women to perform the exercise accurately to straighten their pelvic floor muscles. Much of the cash received from the Series B funding round will get used in developing and testing of four other therapeutic and diagnostic products that include a new version of Leva pelvic digital health system. Also, the fund will assist in future commercial launches, corporate development, product development, and setting up new clinical trials.


The new research trails will help to determine the improvement of women who use the Leva device for strengthening pelvic floor muscle as compared to those who do not use the technology. The trail was to start in August 2018, and the company expected a turn up of over 260 women. Learn more:


Leave a Reply

Your email address will not be published. Required fields are marked *